Cytotoxic T lymphocytes to an unmutated tumor rejection antigen P1A: Normal development but restrained effector function in vivo

Journal of Experimental Medicine

Volumn 189, Issue 5, 1999, Pages 811-820

  Sarma, Supria ^a,d   Guo, Yong ^a,e   Guilloux, Yannik ^a,g   Lee, Cheng ^a,f   Bai, Xue Feng ^a,b,c   Liu, Yang ^a,b,c  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

^e SANOFI   (France)

^f INSERM U463 ^*  (United States)

^g INSTITUT DE BIOLOGIE   (France)

Author keywords

Cytotoxic T lymphocytes; T cell development antitumor immunity; T cell receptor transgenic mice; Unmutated tumor antigen

Indexed keywords

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL FUNCTION; CLONAL ANERGY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; GENETIC CODE; HEMATOPOIETIC CELL; IMMUNOTHERAPY; IN VIVO STUDY; MOUSE; MULTIGENE FAMILY; NONHUMAN; PLASMACYTOMA; PRIORITY JOURNAL; TARGET CELL; TISSUE SPECIFICITY; TUMOR REJECTION;

ANIMALS; ANTIGENS, NEOPLASM; CLONAL DELETION; HEMATOPOIETIC STEM CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; THYMUS GLAND; TISSUE DISTRIBUTION;

EID: 0033103139     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.5.811     Document Type: Article

References (55)

1. Boon, T., J.C. Cerottini, B. Van den Eynde, P. van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337-365.
2. Nanda, N.K., and E.E. Sercarz. 1995. Induction of anti-self-immunity to cure cancer. Cell. 82:13-17.
3. Houghton, A.N. 1994. Cancer antigens: immune recognition of self and altered self. J. Exp. Med. 180:1-4.
4. Jung, S., and H.J. Schluesener. 1991. Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins. J. Exp. Med. 173:273-276.
5. Peace, D.J., W. Chen, H. Nelson, and M.A. Cheever. 1991. T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes. J. Immunol. 146:2059-2065.
6. Skipper, J., and H.J. Stauss. 1993. Identification of two cytotoxic T lymphocyte-recognized epitopes in the Ras protein. J. Exp. Med. 177:1493-1498.
7. + T cells. Proc. Natl. Acad. Sci. USA. 91:3171-3175.
8. Wolfel, T., M. Hauer, J. Schneider, M. Serrano, C. Wolfel, E. Klehmann-Hieb, E. De Plaen, T. Hankeln, K.H. Meyer zum Buschenfelde, and D. Beach. 1995. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science. 269:1281-1284.
9. Dubey, P., R.C. Hendrickson, S.C. Meredith, C.T. Siegel, J. Shabanowitz, J.C. Skipper, V.H. Engelhard, D.F. Hunt, and H. Schreiber. 1997. The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase P68. J. Exp. Med. 185:695-705.
10. Chen, W., D.J. Peace, D.K. Rovira, S.G. You, and M.A. Cheever. 1992. T-cell immunity to the joining region of p210BCR-ABL protein. Proc Natl. Acad. Sci. USA. 89: 1468-1472.
11. Van den Eynde, B., B. Lethe, A. Van Pel, E. De Plaen, and T. Boon. 1991. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. Exp. Med. 173:1373-1384.
12. Traversari, C., P. van der Bruggen, B. Van den Eynde, P. Hainaut, C. Lemoine, N. Ohta, L. Old, and T. Boon. 1992. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics. 35:145-152.
13. van der Bruggen, P., J.P. Szikora, P. Boel, C. Wildmann, M. Somville, M. Sensi, and T. Boon. 1994. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw(Black star)1601. Eur. J. Immunol. 24:2134-2140.
14. Gaugler, B., B. Van den Eynde, P. van der Bruggen, P. Romero, J.J. Gaforio, E. De Plaen, B. Lethe, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179:921-930.
15. Boel, P., C. Wildmann, M.L. Sensi, R. Brasseur, J.C. Renauld, P. Coulie, T. Boon, and P. van der Bruggen. 1995. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity. 2:167-175.
16. Wolfel, T., A. Van Pel, V. Brichard, J. Schneider, B. Seliger, K.H. Meyer zum Buschenfelde, and T. Boon. 1994. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol. 24: 759-764.
17. Kawakami, Y., S. Eliyahu, C.H. Delgado, P.F. Robbins, L. Rivoltini, S.L. Topalian, T. Miki, and S.A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA. 91:3515-3519.
18. Cox, A.L., J. Skipper, Y. Chen, R.A. Henderson, T.L. Darrow, J. Shabanowitz, V.H. Engelhard, D.F. Hunt, and C.L. Slingluff, Jr. 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science. 264:716-719.
19. Guilloux, Y., S. Lucas, V.G. Brichard, A. Van Pel, C. Viret, E. De Plaen, F. Brasseur, B. Lethe, F. Jotereau, and T. Boon. 1996. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J. Exp. Med. 183:1173-1183.
20. Ramarathinam, L., S. Sarma, M. Marie, M. Zhao, G. Yang, L. Chen, and Y. Liu. 1995. Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected. J. Immunol. 155:5323-5329.
21. Pardoll, D.M. 1994. Tumour antigens. A new look for the 1990s. Nature. 369:357.
22. Ada, G. 1989. Prospects for a vaccine against HIV. Nature. 339:331-332.
23. Brichard, V., A. Van Pel, T. Wolfel, C. Wolfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489-495.
24. Uyttenhove, C., C. Godfraind, B. Lethe, A. Amar-Costesec, J.C. Renauld, T.F. Gajewski, M.T. Duffour, G. Warnier, T. Boon, and B.J. Van den Eynde. 1997. The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen. Int. J. Cancer. 70:349-356.
25. van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254:1643-1647.
26. Blackman, M., J. Kappler, and P. Marrack. 1990. The role of the T cell receptor in positive and negative selection of developing T cells. Science. 248:1335-1341.
27. Marrack, P., M. Blackman, H.G. Burgert, J.M. McCormack, J. Gambier, T.H. Finkel, and J. Kappler. 1989. T-cell repertoire and thymus. Cold Spring. Harb. Symp. Quant. Biol. 54: 105-110.
28. Burkly, L.C., D. Lo, O. Kanagawa, R.L. Brinster, and R.A. Flavell. 1989. T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I-E. Nature. 342:564-566.
29. Miller, J.F., and G. Morahan. 1992. Peripheral T cell tolerance. Annu. Rev. Immunol. 10:51-69.
30. + T cells. J. Exp. Med. 186:239-245.
31. Webb, S., C. Morris, and J. Sprent. 1990. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell. 63:1249-1256.
32. Visseren, M.J., A. van Elsas, E.I. van der Voort, M.E. Ressing, W.M. Kast, P.I. Schrier, and C.J. Melief. 1995. CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. J. Immunol. 154: 3991-3998.
33. Rosenberg, S.A., and D.E. White. 1996. Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy. J. Immunother. Emphas. Tumor Immunol. 19:81-84.
34. Ramarathinam, L., M. Castle, Y. Wu, and Y. Liu. 1994. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. J. Exp. Med. 179:1205-1214.
35. Yang, G., K.E. Hellstrom, M.T. Mizuno, and L. Chen. 1995. In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation. J. Immunol. 155:3897-3903.
36. Guo, Y., Y. Wu, M. Zhao, X.P. Kong, and Y. Liu. 1995. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain. J. Exp. Med. 181:1345-1355.
37. Sun, X.H. 1994. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell. 79:893-900.
38. Kouskoff, V., K. Signorelli, C. Benoist, and D. Mathis. 1995. Cassette vectors directing expression of T cell receptor genes in transgenic mice. J. Immunol. Methods. 180:273-280.
39. Lethe, B., B. van den Eynde, A. van Pel, G. Corradin, and T. Boon. 1992. Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide. Eur. J. Immunol. 22:2283-2288.
40. Kisielow, P., H.S. Teh, H. Bluthmann, and H. von Boehmer. 1988. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature. 335:730-733.
41. + memory T cells from the spleen lack MEL-14, the lymph node homing receptor. J. Immunol. 148:324-331.
42. Ehl, S., J. Hombach, P. Aichele, H. Hengartner, and R. Zinkernagel. 1997. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo signifi-cance in transgenic model. J. Exp. Med. 185:1241-1251.
43. Valitutti, S., S. Muller, M. Dessing, and A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917-1921.
44. Targoni, O.S., and P.V. Lehmann. 1998. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187:2055-2063.
45. Yagi, J., and C.A. Janeway, Jr. 1990. Ligand thresholds at different stages of T cell development. Int. Immunol. 2:83-89.
46. Pircher, H., U.H. Rohrer, D. Moskophidis, R.M. Zinkernagel, and H. Hengartner. 1991. Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Nature. 351:482-485.
47. Uyttenhove, C., J. Maryanski, and T. Boon. 1983. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. J. Exp. Med. 157:1040-1052.
48. Rosato, A., A. Zambon, G. Milan, V. Ciminale, D.M. D'Agostino, B. Macino, P. Zanovello, and D. Collavo. 1997. CTL response and protection against P815 tumor challenge in mice immunized with DNA expressing the tumor-specific antigen P815A. Hum. Gene Ther. 8:1451-1458.
49. Chen, P.W., M. Wang, V. Bronte, Y. Zhai, S.A. Rosenberg, and N.P. Restifo. 1996. Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. J. Immunol. 156:224-231.
50. Levraud, J.P., C. Pannetier, P. Langlade-Demoyen, V. Brichard, and P. Kourilsky. 1996. Recurrent T cell receptor rearrangements in the cytotoxic T lymphocyte response in vivo against the P815 murine tumor. J. Exp. Med. 183:439-449.
51. Wick, M., P. Dubey, H. Koeppen, C.T. Siegel, P.E. Fields, L. Chen, J.A. Bluestone, and H. Schreiber. 1997. Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy. J. Exp. Med. 186:229-238.
52. Maric, M., P. Zheng, S. Sarma, Y. Guo, and Y. Liu. 1998. Maturation of cytotoxic T lymphocytes against a B7-transfected nonmetastatic tumor: a critical role for costimulation by B7 on both tumor and host antigen-presenting cells. Cancer Res. 58:3376-3384.
53. Soldevila, G., T. Geiger, and R.A. Flavell. 1995. Breaking immunologic ignorance to an antigenic peptide of simian virus 40 large T antigen. J. Immunol. 155:5590-5600.
54. Harlan, D.M., H. Hengartner, M.L. Huang, Y.H. Kang, R. Abe, R.W. Moreadith, H. Pircher, G.S. Gray, P.S. Ohashi, G.J. Freeman, et al. 1994. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc. Natl. Acad. Sci. USA. 91:3137-3141.
55. Allison, J., L.A. Stephens, T.W. Kay, C. Kurts, W.R. Heath, J.F. Miller, and M.F. Krummel. 1998. The threshold for autoimmune T cell killing is influenced by B7-1. Eur. J. Immunol. 28:949-960.